nach oben

Erschienen in:

01.06.2017 | Sleep Disorders (P Gehrman, Section Editor)

Sleep in Children with Autism Spectrum Disorder

verfasst von: Margaret C. Souders, Stefanie Zavodny, Whitney Eriksen, Rebecca Sinko, James Connell, Connor Kerns, Roseann Schaaf, Jennifer Pinto-Martin

Erschienen in: Current Psychiatry Reports | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

The purposes of this paper are to provide an overview of the state of the science of sleep in children with autism spectrum disorder (ASD), present hypotheses for the high prevalence of insomnia in children with ASD, and present a practice pathway for promoting optimal sleep. Approximately two thirds of children with ASD have chronic insomnia, and to date, the strongest evidence on promoting sleep is for sleep education, environmental changes, behavioral interventions, and exogenous melatonin. The Sleep Committee of the Autism Treatment Network (ATN) developed a practice pathway, based on expert consensus, to capture best practices for screening, identification, and treatment for sleep problems in ASD in 2012. An exemplar case is presented to integrate key constructs of the practice pathway and address arousal and sensory dysregulation in a child with ASD and anxiety disorder. This paper concludes with next steps for dissemination of the practice pathway and future directions for research of sleep problems in ASD.

Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics. 1998;102(3 Pt 1):616–20.PubMedCrossRef

Maquet P. The role of sleep in learning and memory. Science. 2001;294(5544):1048–52. doi:10.1126/science.1062856.PubMedCrossRef

Goodlin-Jones BL, Tang K, Liu J, Anders TF. Sleep patterns in preschool-age children with autism, developmental delay, and typical development. J Am Acad Child Adolesc Psychiatry. 2008;47(8):930–8. doi:10.1097/CHI.ObO13e3181799f7c.PubMedCrossRef

Cohen DV, F. Handbook of autism and pervasive developmental disorders. 2nd ed. Toronto: John Wiley & Sons; 1997.

• Mazurek MO, Sohl K. Sleep and behavioral problems in children with autism Spectrum disorder. J Autism Dev Disord. 2016; doi:10.1007/s10803-016-2723-7. In this study, sleep disturbances in children with ASD are associated with daytime behavioral dysregulation. Night wakings in particular had the strongest correlation with daytime behavior problems, even after controlling for age and sex.PubMed

DeVincent CJ, Gadow KD, Delosh D, Geller L. Sleep disturbance and its relation to DSM-IV psychiatric symptoms in preschool-age children with pervasive developmental disorder and community controls. J Child Neurol. 2007;22(2):161–9. doi:10.1177/0883073807300310.PubMedCrossRef

Robinson-Shelton A, Malow BA. Sleep Disturbances in Neurodevelopmental Disorders. Curr Psychiatry Rep. 2016;18(1):6. doi:10.1007/s11920-015-0638-1.PubMedCrossRef

Christensen CLBJ, Van Naarden Braun K, Bilder D, Charles J, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Lee L, Pettygrove S, Robinson C, Schulz E, Wells C, Wingate MS, Zahorodny W, Yeargin-Allsopp M. Prevalence and characteristics of autism Spectrum disorder among children aged 8 years — Autism and developmental disabilities monitoring Network, 11 sites, United States. MMWR Surveill Summ. 2012;65(3):1–23.CrossRef

Parikshak NN, Luo R, Zhang A, Won H, Lowe JK, Chandran V, et al. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell. 2013;155(5):1008–21. doi:10.1016/j.cell.2013.10.031.PubMedPubMedCentralCrossRef

10.

Werling DM, Parikshak NN, Geschwind DH. Gene expression in human brain implicates sexually dimorphic pathways in autism spectrum disorders. Nat Commun. 2016;7:10717. doi:10.1038/ncomms10717.PubMedPubMedCentralCrossRef

11.

Yang Z, Matsumoto A, Nakayama K, Jimbo EF, Kojima K, Nagata K, et al. Circadian-relevant genes are highly polymorphic in autism spectrum disorder patients. Brain and Development. 2016;38(1):91–9. doi:10.1016/j.braindev.2015.04.006.PubMedCrossRef

12.

Willsey AJ, Sanders SJ, Li M, Dong S, Tebbenkamp AT, Muhle RA, et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell. 2013;155(5):997–1007. doi:10.1016/j.cell.2013.10.020.PubMedPubMedCentralCrossRef

13.

Wood CL, Warnell F, Johnson M, Hames A, Pearce MS, McConachie H, et al. Evidence for ASD recurrence rates and reproductive stoppage from large UK ASD research family databases. Autism Res. 2015;8(1):73–81. doi:10.1002/aur.1414.PubMedCrossRef

14.

Risch N, Hoffmann TJ, Anderson M, Croen LA, Grether JK, Windham GC. Familial recurrence of autism spectrum disorder: Evaluating genetic and environmental contributions. Am J Psychiatry. 2014;171(11):1206–13. doi:10.1176/appi.ajp.2014.13101359.PubMedCrossRef

15.

Eapen V, Crncec R, Walter A. Clinical outcomes of an early intervention program for preschool children with autism Spectrum disorder in a community group setting. BMC Pediatr. 2013;13(1):3. doi:10.1186/1471-2431-13-3.PubMedPubMedCentralCrossRef

16.

Eapen V, Crncec R, Walter A. Exploring links between genotypes, phenotypes, and clinical predictors of response to early intensive behavioral intervention in autism Spectrum disorder. Front Hum Neurosci. 2013;7:567. doi:10.3389/fnhum.2013.00567.PubMedPubMedCentralCrossRef

17.

Kanner L. Problems of nosology and psychodynamics of early infantile autism. Am J Orthop. 1949;19(3):416–26.CrossRef

18.

Kanner L. Irrelevant and metaphorical language in early infantile autism. Am J Psychiatry. 1946;103(2):242–6. doi:10.1176/ajp.103.2.242.PubMedCrossRef

19.

Organization WH. International Classification of Diseases (ICD). 2016.

20.

Lord C, Rutter M, Le Couteur A. Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24(5):659–85.PubMedCrossRef

21.

Association AP. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Publishing; 2013.CrossRef

22.

Owens JA, Mindell JA. Pediatric insomnia. Pediatr Clin N Am. 2011;58(3):555–69. doi:10.1016/j.pcl.2011.03.011.CrossRef

23.

Richdale AL, Schreck KA. Sleep problems in autism spectrum disorders: Prevalence, nature, & possible biopsychosocial aetiologies. Sleep Med Rev. 2009;13(6):403–11. doi:10.1016/j.smrv.2009.02.003.PubMedCrossRef

24.

Wiggs L, Stores G. Sleep patterns and sleep disorders in children with autistic spectrum disorders: Insights using parent report and actigraphy. Dev Med Child Neurol. 2004;46(6):372–80.PubMedCrossRef

25.

Schreck KA, Mulick JA, Smith AF. Sleep problems as possible predictors of intensified symptoms of autism. Res Dev Disabil. 2004;25(1):57–66.PubMedCrossRef

26.

Souders MC, Mason TB, Valladares O, Bucan M, Levy SE, Mandell DS, et al. Sleep behaviors and sleep quality in children with autism spectrum disorders. Sleep. 2009;32(12):1566–78.PubMedPubMedCentralCrossRef

27.

Owens J. Classification and epidemiology of childhood sleep disorders. Prim Care. 2008;35(3):533–546, vii. doi:10.1016/j.pop.2008.06.003.PubMedCrossRef

28.

Malow BA, Crowe C, Henderson L, McGrew SG, Wang L, Song Y, et al. A sleep habits questionnaire for children with autism spectrum disorders. J Child Neurol. 2009;24(1):19–24. doi:10.1177/0883073808321044.PubMedCrossRef

29.

Meltzer LJ. Brief report: Sleep in parents of children with autism spectrum disorders. J Pediatr Psychol. 2008;33(4):380–6. doi:10.1093/jpepsy/jsn005.PubMedCrossRef

30.

Elrod MG, Hood BS. Sleep differences among children with autism spectrum disorders and typically developing peers: A meta-analysis. J Dev Behav Pediatr. 2015;36(3):166–77. doi:10.1097/DBP.0000000000000140.PubMedCrossRef

31.

Bourgeron T. The possible interplay of synaptic and clock genes in autism spectrum disorders. Cold Spring Harb Symp Quant Biol. 2007;72:645–54. doi:10.1101/sqb.2007.72.020.PubMedCrossRef

32.

Malow BA, Adkins KW, Reynolds A, Weiss SK, Loh A, Fawkes D, et al. Parent-based sleep education for children with autism spectrum disorders. J Autism Dev Disord. 2014;44(1):216–28. doi:10.1007/s10803-013-1866-z.PubMedCrossRef

33.

Mindell JA, Meltzer LJ. Behavioural sleep disorders in children and adolescents. Ann Acad Med Singap. 2008;37(8):722–8.PubMed

34.

Meltzer LJ, Johnson C, Crosette J, Ramos M, Mindell JA. Prevalence of diagnosed sleep disorders in pediatric primary care practices. Pediatrics. 2010;125(6):e1410–8. doi:10.1542/peds.2009-2725.PubMedPubMedCentralCrossRef

35.

Tordjman S, Najjar I, Bellissant E, Anderson GM, Barburoth M, Cohen D, et al. Advances in the research of melatonin in autism spectrum disorders: Literature review and new perspectives. Int J Mol Sci. 2013;14(10):20508–42. doi:10.3390/ijms141020508.PubMedPubMedCentralCrossRef

36.

AARC-APT (American Association of Respiratory Care-Association of Polysomnography Technologists) clinical practice guideline. Polysomnography. Respir Care. 1995;40(12):1336–43.

37.

Ornitz EM, Ritvo ER, Brown MB, La Franchi S, Parmelee T, Walter RD. The EEG and rapid eye movements during REM sleep in normal and autistic children. Electroencephalogr Clin Neurophysiol. 1969;26(2):167–75.PubMedCrossRef

38.

Tanguay PE, Ornitz EM, Forsythe AB, Ritvo ER. Rapid eye movement (REM) activity in normal and autistic children during REM sleep. J Autism Child Schizophr. 1976;6(3):275–88.PubMedCrossRef

39.

Diomedi M, Curatolo P, Scalise A, Placidi F, Caretto F, Gigli GL. Sleep abnormalities in mentally retarded autistic subjects: Down's syndrome with mental retardation and normal subjects. Brain and Development. 1999;21(8):548–53.

40.

Elia M, Ferri R, Musumeci SA, Del Gracco S, Bottitta M, Scuderi C, et al. Sleep in subjects with autistic disorder: A neurophysiological and psychological study. Brain and Development. 2000;22(2):88–92.PubMedCrossRef

41.

Godbout R, Bergeron C, Limoges E, Stip E, Mottron L. A laboratory study of sleep in Asperger's syndrome. Neuroreport. 2000;11(1):127–30.PubMedCrossRef

42.

Thirumalai SS, Shubin RA, Robinson R. Rapid eye movement sleep behavior disorder in children with autism. J Child Neurol. 2002;17(3):173–8.PubMedCrossRef

43.

Malow BA, Marzec ML, McGrew SG, Wang L, Henderson LM, Stone WL. Characterizing sleep in children with autism spectrum disorders: A multidimensional approach. Sleep. 2006;29(12):1563–71.PubMedCrossRef

44.

Buckley AW, Rodriguez AJ, Jennison K, Buckley J, Thurm A, Sato S, et al. Rapid eye movement sleep percentage in children with autism compared with children with developmental delay and typical development. Arch Pediatr Adolesc Med. 2010;164(11):1032–7. doi:10.1001/archpediatrics.2010.202.PubMedPubMedCentralCrossRef

45.

Wimpory D, Nicholas B, Nash S. Social timing, clock genes and autism: A new hypothesis. J Intellect Disabil Res. 2002;46(Pt 4):352–8.PubMedCrossRef

46.

Tordjman S, Anderson GM, Pichard N, Charbuy H, Touitou Y. Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biol Psychiatry. 2005;57(2):134–8. doi:10.1016/j.biopsych.2004.11.003.PubMedCrossRef

47.

Tordjman S, Davlantis KS, Georgieff N, Geoffray MM, Speranza M, Anderson GM, et al. Autism as a disorder of biological and behavioral rhythms: Toward new therapeutic perspectives. Front Pediatr. 2015;3:1. doi:10.3389/fped.2015.00001.PubMedPubMedCentralCrossRef

48.

Botbol M, Cabon P, Kermarrec S, Tordjman S. Biological and psychological rhythms: An integrative approach to rhythm disturbances in autistic disorder. J Physiol Paris. 2013;107(4):298–309. doi:10.1016/j.jphysparis.2013.03.009.PubMedCrossRef

49.

Travnickova-Bendova Z, Cermakian N, Reppert SM, Sassone-Corsi P. Bimodal regulation of mPeriod promoters by CREB-dependent signaling and CLOCK/BMAL1 activity. Proc Natl Acad Sci U S A. 2002;99(11):7728–33. doi:10.1073/pnas.102075599.PubMedPubMedCentralCrossRef

50.

Etchegaray JP, Lee C, Wade PA, Reppert SM. Rhythmic histone acetylation underlies transcription in the mammalian circadian clock. Nature. 2003;421(6919):177–82. doi:10.1038/nature01314.PubMedCrossRef

51.

Sasaki M, Yoshitane H, Du NH, Okano T, Fukada Y. Preferential inhibition of BMAL2-CLOCK activity by PER2 reemphasizes its negative role and a positive role of BMAL2 in the circadian transcription. J Biol Chem. 2009;284(37):25149–59. doi:10.1074/jbc.M109.040758.PubMedPubMedCentralCrossRef

52.

Barnes JW, Tischkau SA, Barnes JA, Mitchell JW, Burgoon PW, Hickok JR, et al. Requirement of mammalian Timeless for circadian rhythmicity. Science. 2003;302(5644):439–42. doi:10.1126/science.1086593.PubMedCrossRef

53.

Leroy C, Landais E, Briault S, David A, Tassy O, Gruchy N, et al. The 2q37-deletion syndrome: An update of the clinical spectrum including overweight, brachydactyly and behavioural features in 14 new patients. Eur J Hum Genet. 2013;21(6):602–12. doi:10.1038/ejhg.2012.230.PubMedCrossRef

54.

Nicholas B, Rudrasingham V, Nash S, Kirov G, Owen MJ, Wimpory DC. Association of Per1 and Npas2 with autistic disorder: Support for the clock genes/social timing hypothesis. Mol Psychiatry. 2007;12(6):581–92. doi:10.1038/sj.mp.4001953.PubMedCrossRef

55.

• Veatch OJ, Keenan BT, Gehrman PR, Malow BA, Pack AI. Pleiotropic genetic effects influencing sleep and neurological disorders. Lancet Neurol. 2017;16(2):158–70. doi:10.1016/S1474-4422(16)30339-8. A greater understanding of pleiotropic roles of genes influencing both sleep and neurological disorders could lead to new treatment strategies.PubMedCrossRef

56.

Ritvo ERRR, Yuliwer A, Brothers A, Freeman BJ, Plotkin S. Elevated daytime melatonin concentration in autism. Eur Child Adolesc Psychiatry. 1993;2:75–8.CrossRef

57.

Nir I, Meir D, Zilber N, Knobler H, Hadjez J, Lerner Y. Brief report: Circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism. J Autism Dev Disord. 1995;25(6):641–54.PubMedCrossRef

58.

Kulman G, Lissoni P, Rovelli F, Roselli MG, Brivio F, Sequeri P. Evidence of pineal endocrine hypofunction in autistic children. Neuro Endocrinol Lett. 2000;21(1):31–4.PubMed

59.

Melke J, Goubran Botros H, Chaste P, Betancur C, Nygren G, Anckarsater H, et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry. 2008;13(1):90–8. doi:10.1038/sj.mp.4002016.PubMedCrossRef

60.

Mulder EJ, Anderson GM, Kemperman RF, Oosterloo-Duinkerken A, Minderaa RB, Kema IP. Urinary excretion of 5-hydroxyindoleacetic acid, serotonin and 6-sulphatoxymelatonin in normoserotonemic and hyperserotonemic autistic individuals. Neuropsychobiology. 2010;61(1):27–32. doi:10.1159/000258640.PubMedCrossRef

61.

Veatch OJ, Veenstra-Vanderweele J, Potter M, Pericak-Vance MA, Haines JL. Genetically meaningful phenotypic subgroups in autism spectrum disorders. Genes Brain Behav. 2014;13(3):276–85. doi:10.1111/gbb.12117.PubMedCrossRef

62.

Chaste P, Clement N, Mercati O, Guillaume JL, Delorme R, Botros HG, et al. Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population. PLoS One. 2010;5(7):e11495. doi:10.1371/journal.pone.0011495.PubMedPubMedCentralCrossRef

63.

Jonsson L, Ljunggren E, Bremer A, Pedersen C, Landen M, Thuresson K, et al. Mutation screening of melatonin-related genes in patients with autism spectrum disorders. BMC Med Genet. 2010;3:10. doi:10.1186/1755-8794-3-10.

64.

Gupta R, Hutchins J. Melatonin: A panacea for desperate parents? (hype or truth). Arch Dis Child. 2005;90(9):986–7. doi:10.1136/adc.2005.075218.PubMedPubMedCentralCrossRef

65.

Andersen IM, Kaczmarska J, McGrew SG, Malow BA. Melatonin for insomnia in children with autism spectrum disorders. J Child Neurol. 2008;23(5):482–5. doi:10.1177/0883073807309783.PubMedCrossRef

66.

Galli-Carminati G, Deriaz N, Bertschy G. Melatonin in treatment of chronic sleep disorders in adults with autism: A retrospective study. Swiss Med Wkly. 2009;139(19–20):293–6.PubMed

67.

Jan JE, Espezel H, Appleton RE. The treatment of sleep disorders with melatonin. Dev Med Child Neurol. 1994;36(2):97–107.PubMedCrossRef

68.

Ishizaki A, Sugama M, Takeuchi N. Usefulness of melatonin for developmental sleep and emotional/behavior disorders--studies of melatonin trial on 50 patients with developmental disorders. No To Hattatsu. 1999;31(5):428–37.PubMed

69.

Paavonen EJ, Nieminen-von Wendt T, Vanhala R, Aronen ET, von Wendt L. Effectiveness of melatonin in the treatment of sleep disturbances in children with Asperger disorder. J Child Adolesc Psychopharmacol. 2003;13(1):83–95. doi:10.1089/104454603321666225.PubMedCrossRef

70.

Giannotti F, Cortesi F, Cerquiglini A, Bernabei P. An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. J Autism Dev Disord. 2006;36(6):741–52. doi:10.1007/s10803-006-0116-z.PubMedCrossRef

71.

De Leersnyder H, Zisapel N, Laudon M. Prolonged-release melatonin for children with neurodevelopmental disorders. Pediatr Neurol. 2011;45(1):23–6. doi:10.1016/j.pediatrneurol.2011.02.001.PubMedCrossRef

72.

Malow BAAK, McGrew S, Wang L, Goldman S, Fawkes D, Burnette C. Melatonin for sleep in children with autism: A controlled trial examining dose, tolerability and outcomes. J Autism Dev Disord. 2011;42.

73.

McArthur AJ, Budden SS. Sleep dysfunction in Rett syndrome: A trial of exogenous melatonin treatment. Dev Med Child Neurol. 1998;40(3):186–92.PubMedCrossRef

74.

Garstang J, Wallis M. Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child Care Health Dev. 2006;32(5):585–9. doi:10.1111/j.1365-2214.2006.00616.x.PubMedCrossRef

75.

Wasdell MB, Jan JE, Bomben MM, Freeman RD, Rietveld WJ, Tai J, et al. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res. 2008;44(1):57–64. doi:10.1111/j.1600-079X.2007.00528.x.PubMed

76.

Wirojanan J, Jacquemont S, Diaz R, Bacalman S, Anders TF, Hagerman RJ, et al. The efficacy of melatonin for sleep problems in children with autism, fragile X syndrome, or autism and fragile X syndrome. J Clin Sleep Med. 2009;5(2):145–50.PubMedPubMedCentral

77.

Wright B, Sims D, Smart S, Alwazeer A, Alderson-Day B, Allgar V, et al. Melatonin versus placebo in children with autism spectrum conditions and severe sleep problems not amenable to behaviour management strategies: A randomised controlled crossover trial. J Autism Dev Disord. 2011;41(2):175–84. doi:10.1007/s10803-010-1036-5.PubMedCrossRef

78.

Cortesi F, Giannotti F, Sebastiani T, Panunzi S, Valente D. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: A randomized placebo-controlled trial. J Sleep Res. 2012;21(6):700–9. doi:10.1111/j.1365-2869.2012.01021.x.PubMedCrossRef

79.

Gringras P, Gamble C, Jones AP, Wiggs L, Williamson PR, Sutcliffe A, et al. Melatonin for sleep problems in children with neurodevelopmental disorders: Randomised double masked placebo controlled trial. BMJ. 2012;345:e6664. doi:10.1136/bmj.e6664.PubMedPubMedCentralCrossRef

80.

Goldman SE, Adkins KW, Calcutt MW, Carter MD, Goodpaster RL, Wang L, et al. Melatonin in children with autism spectrum disorders: Endogenous and pharmacokinetic profiles in relation to sleep. J Autism Dev Disord. 2014;44(10):2525–35. doi:10.1007/s10803-014-2123-9.PubMedPubMedCentralCrossRef

81.

Hall M, Buysse DJ, Dew MA, Prigerson HG, Kupfer DJ, Reynolds 3rd CF. Intrusive thoughts and avoidance behaviors are associated with sleep disturbances in bereavement-related depression. Depress Anxiety. 1997;6(3):106–12.PubMedCrossRef

82.

Levenson JC, Kay DB, Buysse DJ. The pathophysiology of insomnia. Chest. 2015;147(4):1179–92. doi:10.1378/chest.14-1617.PubMedPubMedCentralCrossRef

83.

Perlis ML, Smith MT, Orff H, Enright T, Nowakowski S, Jungquist C, et al. The effects of modafinil and cognitive behavior therapy on sleep continuity in patients with primary insomnia. Sleep. 2004;27(4):715–25.PubMedCrossRef

84.

Bonnet MH, Arand DL. Hyperarousal and insomnia: State of the science. Sleep Med Rev. 2010;14(1):9–15. doi:10.1016/j.smrv.2009.05.002.PubMedCrossRef

85.

Feige B, Baglioni C, Spiegelhalder K, Hirscher V, Nissen C, Riemann D. The microstructure of sleep in primary insomnia: An overview and extension. Int J Psychophysiol. 2013;89(2):171–80. doi:10.1016/j.ijpsycho.2013.04.002.PubMedCrossRef

86.

Healey ES, Kales A, Monroe LJ, Bixler EO, Chamberlin K, Soldatos CR. Onset of insomnia: Role of life-stress events. Psychosom Med. 1981;43(5):439–51.PubMedCrossRef

87.

Morin CM, Rodrigue S, Ivers H. Role of stress, arousal, and coping skills in primary insomnia. Psychosom Med. 2003;65(2):259–67.PubMedCrossRef

88.

Hutt C, Hutt SJ, Lee D, Ounsted C. Arousal and childhood autism. Nature. 1964;204:908–9.PubMedCrossRef

89.

Dawson G, Finley C, Phillips S, Galpert L, Lewy A. Reduced P3 amplitude of the event-related brain potential: Its relationship to language ability in autism. J Autism Dev Disord. 1988;18(4):493–504.PubMedCrossRef

90.

van Engeland H. The electrodermal orienting response to auditive stimuli in autistic children, normal children, mentally retarded children, and child psychiatric patients. J Autism Dev Disord. 1984;14(3):261–79.PubMedCrossRef

91.

Barry RJ, James AL. Coding of stimulus parameters in autistic, retarded, and normal children: Evidence for a two-factor theory of autism. Int J Psychophysiol. 1988;6(2):139–49.PubMedCrossRef

92.

Palkovitz RJ, Wiesenfeld AR. Differential autonomic responses of autistic and normal children. J Autism Dev Disord. 1980;10(3):347–60.PubMedCrossRef

93.

Hirstein W, Iversen P, Ramachandran VS. Autonomic responses of autistic children to people and objects. Proc Biol Sci. 2001;268(1479):1883–8.PubMedPubMedCentralCrossRef

94.

Ming X, Julu PO, Brimacombe M, Connor S, Daniels ML. Reduced cardiac parasympathetic activity in children with autism. Brain and Development. 2005;27(7):509–16.PubMedCrossRef

95.

Reynolds S, Lane SJ, Thacker L. Sensory processing, physiological stress, and sleep behaviors in children with and without autism spectrum disorders. Occupational Therapy Journal of Research. 2012;32(1). doi:10.3928/15394492-20110513-02.

96.

McIntosh DN, Miller LJ, Shyu V. Development and validation of the short sensory profile. In: Dunn W, editor. Sensory profile manual. San Antonio: Psychological Corporation; 1999. p. 59–73.

97.

McIntosh DN, Miller LJ, Shyu V, Hagerman RJ. Sensory-modulation disruption, electrodermal responses, and functional behaviors. Developmental Medicine & Child Neurology. 1999;41(9):608–15. doi:10.1111/j.1469-8749.1999.tb00664.x.CrossRef

98.

Dunn W. The sensory profile. San Antonio: The Psychological Corporation; 1999.

99.

• Mazurek MO, Petroski GF. Sleep problems in children with autism spectrum disorder: Examining the contributions of sensory over-responsivity and anxiety. Sleep Med. 2015;16(2):270–9. doi:10.1016/j.sleep.2014.11.006. This study included 1, 347 children with ASD and revealed strong relationships among anxiety, sensory over-responsivity, and sleep disturbance, due to a state of hyperarousal.PubMedCrossRef

100.

• Hollway JA, Aman MG, Butter E. Correlates and risk markers for sleep disturbance in participants of the autism treatment Network. J Autism Dev Disord. 2013;43(12):2830–43. doi:10.1007/s10803-013-1830-y. This study found that GI disturbance, autism symptom severity, anxiety, and sensory sensitivities are correlated with sleep disturbances. IQ predicted sleep disturbances, suggesting that children with Asperger’s Disorder are vulnerable to sleep disturbances.PubMedCrossRef

101.

White SW, Lerner MD, McLeod BD, Wood JJ, Ginsburg GS, Kerns C, et al. Anxiety in youth with and without autism spectrum disorder: Examination of factorial equivalence. Behav Ther. 2015;46(1):40–53. doi:10.1016/j.beth.2014.05.005.PubMedCrossRef

102.

Kerns CM, Maddox BB, Kendall PC, Rump K, Berry L, Schultz RT, et al. Brief measures of anxiety in non-treatment-seeking youth with autism spectrum disorder. Autism. 2015;19(8):969–79. doi:10.1177/1362361314558465.PubMedCrossRef

103.

Kerns CM, Kendall PC, Berry L, Souders MC, Franklin ME, Schultz RT, et al. Traditional and atypical presentations of anxiety in youth with autism spectrum disorder. J Autism Dev Disord. 2014;44(11):2851–61. doi:10.1007/s10803-014-2141-7.PubMedCrossRefPubMedCentral

104.

Yerys BE, Wallace GL, Sokoloff JL, Shook DA, James JD, Kenworthy L. Attention deficit/hyperactivity disorder symptoms moderate cognition and behavior in children with autism spectrum disorders. Autism Res. 2009;2(6):322–33. doi:10.1002/aur.103.PubMedPubMedCentral

105.

Aston-Jones G, Rajkowski J, Cohen J. Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry. 1999;46(9):1309–20.PubMedCrossRef

106.

Aston-Jones G, Cohen JD. An integrative theory of locus coeruleus-norepinephrine function: Adaptive gain and optimal performance. Annu Rev Neurosci. 2005;28:403–50.PubMedCrossRef

107.

Panju S, Brian J, Dupuis A, Anagnostou E, Kushki A. Atypical sympathetic arousal in children with autism spectrum disorder and its association with anxiety symptomatology. Mol Autism. 2015;6:64. doi:10.1186/s13229-015-0057-5.PubMedPubMedCentralCrossRef

108.

Brennan AR, Arnsten AF. Neuronal mechanisms underlying attention deficit hyperactivity disorder: The influence of arousal on prefrontal cortical function. Ann N Y Acad Sci. 2008;1129:236–45.PubMedPubMedCentralCrossRef

109.

Swanson LW. The locus coeruleus: A cytoarchitectonic, Golgi and immunohistochemical study in the albino rat. Brain Res. 1976;110(1):39–56.PubMedCrossRef

110.

Swanson LW, Hartman BK. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J Comp Neurol. 1975;163(4):467–505.PubMedCrossRef

111.

Aston-Jones G, Bloom FE. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci. 1981;1(8):876–86.PubMed

112.

Aston-Jones G, Bloom FE. Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. J Neurosci. 1981;1(8):887–900.PubMed

113.

Valentino RJ, Van Bockstaele E. Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol. 2008;583(2–3):194–203.PubMedPubMedCentralCrossRef

114.

Berridge CW, Schmeichel BE, Espana RA. Noradrenergic modulation of wakefulness/arousal. Sleep Med Rev. 2012;16(2):187–97. doi:10.1016/j.smrv.2011.12.003.PubMedPubMedCentralCrossRef

115.

Renton GH, Weil-Malherbe H. Adrenaline and noradrenaline in human plasma during natural sleep. J Physiol. 1956;131(1):170–5.PubMedPubMedCentralCrossRef

116.

Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am. 1987;10(4):541–53.PubMed

117.

• Malow BA, Byars K, Johnson K, Weiss S, Bernal P, Goldman SE, et al. A practice pathway for the identification, evaluation, and management of insomnia in children and adolescents with autism spectrum disorders. Pediatrics. 2012;130(Suppl 2):S106–24. doi:10.1542/peds.2012-0900I. This is the first consensus paper to provide a practical algorithm supporting decision-making for providers caring for children with ASD and insomnia.PubMedCrossRef

118.

Linehan MM. Skills training manual for treating borderline personality disorder. The Guilford Press; 1993.

119.

Kid N. Yoga for Kids. 2016.

120.

Silva LM, Cignolini A. A medical qigong methodology for early intervention in autism spectrum disorder: A case series. Am J Chin Med. 2005;33(2):315–27. doi:10.1142/S0192415X05002837.PubMedCrossRef

121.

Silva LM, Cignolini A, Warren R, Budden S, Skowron-Gooch A. Improvement in sensory impairment and social interaction in young children with autism following treatment with an original qigong massage methodology. Am J Chin Med. 2007;35(3):393–406. doi:10.1142/S0192415X07004916.PubMedCrossRef

122.

Silva LM, Schalock M, Ayres R, Bunse C, Budden S. Qigong massage treatment for sensory and self-regulation problems in young children with autism: A randomized controlled trial. Am J Occup Ther. 2009;63(4):423–32.PubMedCrossRef

123.

Silva LM, Schalock M, Gabrielsen K. Early intervention for autism with a parent-delivered qigong massage program: A randomized controlled trial. Am J Occup Ther. 2011;65(5):550–9.PubMedCrossRef

124.

Hanh TN. Mindful movements: Ten exercises for well-being. Berkley: Parralax Press; 2008.

125.

Dadoly A. Two techniques for reducing stress. 2011. www.health.harvard.edu/blog/two-techniques-for-reducing-stress-201104092235.

126.

Owens JA, Spirito A, McGuinn M. The Children's Sleep Habits Questionnaire (CSHQ): Psychometric properties of a survey Instrument for school-aged children. Sleep. 2000;23(8):1043–51.

127.

Research Units on Pediatric Psychopharmacology Anxiety Study Group. The pediatric anxiety rating scale (PARS): Development and psychometric properties. J Am Acad Child Adolesc Psychiatry. 2002;41:1061–1069.

128.

Storch EA, Wood JJ, Ehrenreich-May J, Jones AM, Park JM, Lewin AB, et al. Convergent and discriminant validity and reliability of the pediatric anxiety rating scale in youth with autism spectrum disorders. J Autism Dev Disord. 2012;42(11):2374–82. doi:10.1007/s10803-012-1489-9.PubMedCrossRef

129.

Kerns CM, Renno, P. Kendall, P. C., Wood, J.J., & Storch, E. A. Anxiety Disorders Interview Schedule – Autism Addendum: Reliability and Validity in Children with Autism Spectrum Disorder. Journal of Child Clinical and Adolescent Psychology. 2017.

130.

Kerns CM, Wood JJ, Kendall PC, Renno P, Crawford EA, Mercado RJ, et al. The Treatment of Anxiety in Autism Spectrum Disorder (TAASD) study: rationale, design and methods. Journal of Child and Family Studies. 2016;25(6):1889–902.

131.

Storch EA, Arnold EB, Lewin AB, Nadeau JM, Jones AM, De Nadai AS, et al. The effect of cognitive-behavioral therapy versus treatment as usual for anxiety in children with autism spectrum disorders: A randomized, controlled trial. J Am Acad Child Adolesc Psychiatry. 2013;52(2):132–142 e2. doi:10.1016/j.jaac.2012.11.007.PubMedCrossRef

132.

Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M. Psychometric properties of the screen for child anxiety related emotional disorders (SCARED): A replication study. J Am Acad Child Adolesc Psychiatry. 1999;38(10):1230–6. doi:10.1097/00004583-199910000-00011.PubMedCrossRef

133.

Birmaher B, Khetarpal S, Brent D, Cully M, Balach L, Kaufman J, et al. The screen for child anxiety related emotional disorders (SCARED): Scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry. 1997;36(4):545–53. doi:10.1097/00004583-199704000-00018.PubMedCrossRef

134.

Reaven JA, Blakeley-Smith A, Nichols S, Dasari M, Flanigan E, Hepburn S. Cognitive-behavioral group treatment for anxiety symptoms in children with high-functioning autism spectrum disorders a pilot study. Focus on Autism and Other Developmental Disabilities. 2009;24(1):27–37.CrossRef

Titel: Sleep in Children with Autism Spectrum Disorder
verfasst von: Margaret C. Souders
Stefanie Zavodny
Whitney Eriksen
Rebecca Sinko
James Connell
Connor Kerns
Roseann Schaaf
Jennifer Pinto-Martin
Publikationsdatum: 01.06.2017
Verlag: Springer US
Erschienen in: Current Psychiatry Reports / Ausgabe 6/2017
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI: https://doi.org/10.1007/s11920-017-0782-x

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2017

Men, Muscles, and Eating Disorders: an Overview of Traditional and Muscularity-Oriented Disordered Eating

Biomarkers of Suicide Attempt Behavior: Towards a Biological Model of Risk

Update on Barriers to Pharmacotherapy for Opioid Use Disorders

Sex Differences in Obesity and Mental Health